For those preparing for certification or recertification in hematology or oncology, Hoffman and Abeloff's Hematology-Oncology Review is a single-volume source of authoritative, up-to-date exam preparation. This unique question and answer review helps you succeed on today’s board exams with more than 1,000 board-style questions, answers, and rationales; comprehensive coverage of essential exam topics, and online practice tests.
1. Instructions for online access - p. 385 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedications - p. v 7. Contributors - p. vii 8. Preface - p. x 9. Science and Therapy - p. x 10. Section 1. Cancer Biology, Genomics, and Immunology - p. x 11. Chapter 1. Cancer Biology - p. 1 12. Chapter 2. Tumor Immunology - p. 4 13. Section 2. Anti-Cancer Therapies - p. 6 14. Chapter 3. Cancer Chemotherapy - p. 7 15. Chapter 4. Immunotherapy and Pathway Inhibitors - p. 13 16. Part 2. Hematologic Malignancies - p. 17 17. Chapter 5. Acute Myeloid Leukemia and Myelodysplastic Syndrome - p. 18 18. Chapter 6. Myeloproliferative Disorders - p. 22 19. Chapter 7. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and Other Chronic Lymphoproliferative Disorders - p. 26 20. Chapter 8. Hodgkin Lymphoma - p. 30 21. Chapter 9. Non-Hodgkin Lymphoma - p. 34 22. Chapter 10. Multiple Myeloma and Other Plasma Cell Dyscrasias - p. 41 23. Chapter 11. T-Cell and Natural Killer Cell Neoplasms and Other Lymphoid Malignancies - p. 45 24. Chapter 12. Hematopoietic Cell Transplantation - p. 47 25. Part 3. Solid Tumor Malignancies - p. 56 26. Chapter 13. Breast Cancer - p. 57 27. Early-Stage Breast Cancer - p. 57 28. Metastatic Breast Cancer - p. 77 29. Premalignant Breast Cancer Conditions and In Situ Disease - p. 90 30. Chapter 14. Lung Cancer - p. 98 31. Chapter 15. Other Thoracic Malignancies - p. 112 32. Chapter 16. Head and Neck Cancer - p. 118 33. Chapter 17. Esophageal Cancer - p. 128 34. Chapter 18. Gastric Cancer - p. 133 35. Chapter 19. Pancreatic Cancer - p. 136 36. Chapter 20. Colorectal and Anal Cancer - p. 139 37. Chapter 21. Hepatobiliary Cancer - p. 151 38. Chapter 22. Neuroendocrine, Small Bowel, and Appendiceal Malignancies - p. 154 39. Chapter 23. Prostate Cancer - p. 160 40. Chapter 24. Bladder and Other Urothelial Cancers - p. 172 41. Chapter 25. Renal Cell Carcinoma - p. 179 42. Chapter 26. Germ Cell Tumor - p. 185 43. Chapter 27. Gynecological Malignancies - p. 190 44. Chapter 28. Melanoma and Other Skin Cancers - p. 206 45. Chapter 29. Bone and Soft Tissue Sarcoma - p. 213 46. Chapter 30. Unknown Primary Site - p. 223 47. Chapter 31. Malignancies of the Central Nervous System - p. 228 48. Chapter 32. Hereditary Cancer Syndromes - p. 235 49. Part 4. Non-Malignant Hematologic Conditions - p. 239 50. Chapter 33. Coagulation - p. 240 51. Chapter 34. Hematopoietic System Disorders - p. 296 52. Chapter 35. Transfusion Medicine - p. 357 53. Part 5. Survivorship and End of Life Care - p. 367 54. Chapter 36. Pain Control and End of Life - p. 368 55. Chapter 37. Survivorship and Treatment-Related Issues - p. 376
No hay muestra disponible
No hay ficha técnica disponible
For those preparing for certification or recertification in hematology or oncology, Hoffman and Abeloff's Hematology-Oncology Review is a single-volume source of authoritative, up-to-date exam preparation. This unique question and answer review helps you succeed on today’s board exams with more than 1,000 board-style questions, answers, and rationales; comprehensive coverage of essential exam topics, and online practice tests.
1. Instructions for online access - p. 385 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedications - p. v 7. Contributors - p. vii 8. Preface - p. x 9. Science and Therapy - p. x 10. Section 1. Cancer Biology, Genomics, and Immunology - p. x 11. Chapter 1. Cancer Biology - p. 1 12. Chapter 2. Tumor Immunology - p. 4 13. Section 2. Anti-Cancer Therapies - p. 6 14. Chapter 3. Cancer Chemotherapy - p. 7 15. Chapter 4. Immunotherapy and Pathway Inhibitors - p. 13 16. Part 2. Hematologic Malignancies - p. 17 17. Chapter 5. Acute Myeloid Leukemia and Myelodysplastic Syndrome - p. 18 18. Chapter 6. Myeloproliferative Disorders - p. 22 19. Chapter 7. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and Other Chronic Lymphoproliferative Disorders - p. 26 20. Chapter 8. Hodgkin Lymphoma - p. 30 21. Chapter 9. Non-Hodgkin Lymphoma - p. 34 22. Chapter 10. Multiple Myeloma and Other Plasma Cell Dyscrasias - p. 41 23. Chapter 11. T-Cell and Natural Killer Cell Neoplasms and Other Lymphoid Malignancies - p. 45 24. Chapter 12. Hematopoietic Cell Transplantation - p. 47 25. Part 3. Solid Tumor Malignancies - p. 56 26. Chapter 13. Breast Cancer - p. 57 27. Early-Stage Breast Cancer - p. 57 28. Metastatic Breast Cancer - p. 77 29. Premalignant Breast Cancer Conditions and In Situ Disease - p. 90 30. Chapter 14. Lung Cancer - p. 98 31. Chapter 15. Other Thoracic Malignancies - p. 112 32. Chapter 16. Head and Neck Cancer - p. 118 33. Chapter 17. Esophageal Cancer - p. 128 34. Chapter 18. Gastric Cancer - p. 133 35. Chapter 19. Pancreatic Cancer - p. 136 36. Chapter 20. Colorectal and Anal Cancer - p. 139 37. Chapter 21. Hepatobiliary Cancer - p. 151 38. Chapter 22. Neuroendocrine, Small Bowel, and Appendiceal Malignancies - p. 154 39. Chapter 23. Prostate Cancer - p. 160 40. Chapter 24. Bladder and Other Urothelial Cancers - p. 172 41. Chapter 25. Renal Cell Carcinoma - p. 179 42. Chapter 26. Germ Cell Tumor - p. 185 43. Chapter 27. Gynecological Malignancies - p. 190 44. Chapter 28. Melanoma and Other Skin Cancers - p. 206 45. Chapter 29. Bone and Soft Tissue Sarcoma - p. 213 46. Chapter 30. Unknown Primary Site - p. 223 47. Chapter 31. Malignancies of the Central Nervous System - p. 228 48. Chapter 32. Hereditary Cancer Syndromes - p. 235 49. Part 4. Non-Malignant Hematologic Conditions - p. 239 50. Chapter 33. Coagulation - p. 240 51. Chapter 34. Hematopoietic System Disorders - p. 296 52. Chapter 35. Transfusion Medicine - p. 357 53. Part 5. Survivorship and End of Life Care - p. 367 54. Chapter 36. Pain Control and End of Life - p. 368 55. Chapter 37. Survivorship and Treatment-Related Issues - p. 376
No hay muestra disponible
No hay ficha técnica disponible
